Novotech, the leading global biotech Contract Research Organization (CRO), has announced the appointment of Dr Yooni Kim as a new Executive position of Managing Director for the Asia-Pacific (APAC) region, effective September 1, 2024.

The establishment of the Managing Director APAC role is a significant step, aligning Novotech’s operations across key regions, including the United States, Europe, Mainland China, and APAC.

Dr Yooni Kim brings extensive expertise and leadership experience to her new role, with over 25 years’ experience in the clinical research sector of academia, CROs and pharmaceutical companies.

Her leadership was proven by a quantum leap in business growth in the APAC region within the CRO industry. Dr Yooni joined Novotech in 2016 as Executive Director, where she played a pivotal role in the growth of the company’s business in Asia.

Following the PPC group merger in 2019, she served as Vice President of Global Clinical Services, leading the Novotech’s global clinical services departments and harmonizing Novotech’s approach to clinical trials with stakeholders globally. 

In her new role as Managing Director for APAC, Dr Yooni will lead Novotech’s APAC from providing strategic direction to diverse teams and ensuring operational excellence in the region.